Affordable Access

deepdyve-link
Publisher Website

The Epigenetic Modification of Epigallocatechin Gallate (EGCG) on Cancer.

Authors
  • Yang, Linqi1
  • Zhang, Wenqi2
  • Chopra, Saiyam2
  • Kaur, Deeepjyot2
  • Wang, Huibing1
  • Li, Meng1
  • Chen, Pingping1
  • Zhang, Wei1
  • 1 Department of Pharmacology, School of Basic Medical Sciences, Hebei University of Chinese Medicine, Shijiazhuang 050200, Hebei Province, China. , (China)
  • 2 College of Basic Medicine, Hebei Medical University, Shijiazhuang 050017, Hebei Province, China. , (China)
Type
Published Article
Journal
Current drug targets
Publication Date
Jan 01, 2020
Volume
21
Issue
11
Pages
1099–1104
Identifiers
DOI: 10.2174/1389450121666200504080112
PMID: 32364072
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Among the major components of green tea, epigallocatechin-3-gallate (EGCG) is the most effective for its anti-cancer characteristics. The bulk of studies provide the mechanisms of suppressive function of EGCG are involved in alteration of cancer cell cycle, development, and apoptosis through activation/inhibition of several signal pathways. Another mechanism that explains the multiple effects exerted by EGCG in cancer is the epigenetic change by DNA methylation or methyltransferases, histone acetylation or deacetylases, and no coding RNAs (micoRNAs). Furthermore, decontrolled expression of miRNA transcription has been tested to be directly regulated by oncogenic and tumor-suppressor transcription factors. Recently, several proteins have been identified as miRNA direct interactors by EGCG. However, the mechanisms explaining the action of miRNA being modulated by EGCG have not been completely understood yet. This review summarizes the state of epigenetic change being modulated by EGCG in a variety of cancers and oncogenic and tumor-suppressor transcription factors. Copyright© Bentham Science Publishers; For any queries, please email at [email protected]

Report this publication

Statistics

Seen <100 times